Kevin Bozymski is a pharmacist who is specialized in Psychiatric in Milwaukee, Wisconsin. Patients can reach him at 1155 N Mayfair Rd, Milwaukee or contact him on 414-955-8950. Active license number of Kevin Bozymski is 18943-40 for Psychiatric in Wisconsin. Kevin Bozymski is a licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Complete Profile:
Kevin Bozymski speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Kevin Bozymski
Specialization:
Psychiatric
Credentials:
PHARMD, BCPS
Gender:
Male
Location:
1155 N Mayfair Rd, Milwaukee, Wisconsin, 53226-3462
Phone:
414-955-8950
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Kevin Bozymski are as mentioned below.
NPI Number:
1003326745
NPI Enumeration Date:
09 Oct, 2017
NPI Last Update On:
18 Oct, 2017
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Kevin Bozymski are as mentioned below.
Specialization
License Number
State
Status
Psychiatric
18943-40
Wisconsin
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
8701 W Watertown Plank Rd, Milwaukee, Wisconsin
Zip:
53226-3548
Phone Number:
--
Fax Number:
--
Patients can reach Kevin Bozymski at 1155 N Mayfair Rd, Milwaukee, Wisconsin or can call on phone at 414-955-8950.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.